Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Multimeric bispecific binding molecules specific for CD20 and CD3

Multimeric bispecific binding molecules specific for CD20 and CD3

US Patent 10787520 · Granted Sep 29, 2020

Estimated economic value: $44,169,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Anti-CD19/anti-CD38 common light chain bispecific antibodies2025
Binding molecules with modified J-chain2025
Binding molecules with modified J-chain2025
CD25 antibodies2025
Modified Fc proteins comprising site-specific non-natural amino acid residues, c2025
Antibodies comprising site-specific non-natural amino acid residues, methods of 2024
Cup2024
Antibodies to TIGIT2023
Binding molecules with modified J-chain2023
Binding molecules with modified J-chain2023
High-lift shielded permanent magnet multistage pump and control method2023
Polynucleotides encoding death domain-containing receptor-5 (DR5) binding molecu2023